TMPRSS2 and pachyonychia congenita: The 10 leading-edge genes of this enrichment are novel to PC; they display differential expression in PC compared to normal prostate tissue, PCs with TMPRSS2-ERG fusion compared to those without the fusion, and mPCs compared to primary PC.